The major sterols from three species of polyporaceae

Kac, D.; Barbieri, Giovanna; Falco, M. R.; Seldes, Alicia M.; Gros, Eduardo G.

doi:10.1016/s0031-9422(00)84132-1

Cited by 17 publications

(10 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Understandably, the authors put a disclaimer about the taxonomic veracity of the names they use in the volumes. (Strigina et al, 1971;Domínguez et al, 1972;Ripperger and Budzikiewicz, 1975;Jain and Gupta, 1984;Kac et al, 1984;Tomoda et al, 1986;Nishitoba et al, 1987;Shiao et al, 1988;Chairul et al, 1991;Hirotani et al, 1991Hirotani et al, , 1995Lin et al, 1993;Kawagishi et al, 1993;Sofni et al, 1994;Kawagishi et al, 1997;Keller et al, 1997;Lin et al, 1997;El-Mekkawy et al, 1998; Rö secke and Kö nig, 2000; Bao et al, 2002;Ziegenbein et al, 2006). Furthermore, Akihisa et al (2005) describe (a) two triterpenoids: 20(21)-dehydrolucidenic acid A and methyl 20(21)-dehydrolucidenate A, and (b) five new 20-hydroxylucidenic acids: 20-hydroxylucidenic acid D 2 , 20-hydroxylucidenic acid F, 20-hydroxylucidenic acid E 2 , 20-hydroxylucidenic acid N, and 20-hydroxylucidenic acid P isolated from the basidiocarps of G. ludicum.…”

Section: Chemical Constituentsmentioning

confidence: 99%

Ganoderma – A therapeutic fungal biofactory

2006

View full text Add to dashboard Cite

Ganoderma is a basidiomycete white rot fungus which has been used for medicinal purposes for centuries particularly in China, Japan and Korea. A great deal of work has been carried out on Ganoderma lucidum. The common names for preparations include Lingzhi, Munnertake, Sachitake, Reishi and Youngzhi. This review collates the publications detailing activities and compounds by representative species whilst considering the most valid claims of effectiveness. The biological activities reported of preparations from Ganoderma are remarkable and given most emphasis herein as distinct from structure/activity information. The metabolites consist of mainly polysaccharides and terpenoids. Many are activities against the major diseases of our time and so the present review is of great importance. The list of effects is huge ranging from anti-cancer to relieving blockages of the bladder. However, the reports have not all been tested scientifically with the convincing evidence is reserved for assays of pure compounds. It is a prime example of an ancient remedy being of great relevance to the modern era. There does appear to be an assumption that the therapeutic effects attributed to the fungus have been proven. The next step is to produce some effective medicines which may be hampered by problems of mass production.

show abstract

Section: Chemical Constituentsmentioning

confidence: 99%

Ganoderma – A therapeutic fungal biofactory

2006

View full text Add to dashboard Cite

show abstract

“…Understandably, the authors put a disclaimer about the taxonomic veracity of the names they use in the volumes. 3,7,11,15, (Strigina et al, 1971;Domínguez et al, 1972;Ripperger and Budzikiewicz, 1975;Jain and Gupta, 1984;Kac et al, 1984;Tomoda et al, 1986;Nishitoba et al, 1987;Shiao et al, 1988;Chairul et al, 1991;Hirotani et al, 1991Hirotani et al, , 1995Lin et al, 1993;Kawagishi et al, 1993;Sofni et al, 1994;Kawagishi et al, 1997;Keller et al, 1997;Lin et al, 1997;El-Mekkawy et al, 1998 (22)-dien-26oic acid methyl ester. The authors suggest that more of these classes of compounds will be detected in future studies.…”

Section: Chemical Constituentsmentioning

confidence: 99%

Ganoderma — A Therapeutic Fungal Biofactory

Paterson¹

2006

ChemInform

124

View full text Add to dashboard Cite

show abstract

“…Kim & B. Kim, 1999;Paterson, 2006;Zhou et al, 2007). There exist several reports about the isolation of lanostane-type triterpenes (Boh, Hodzˇar, Dolnicˇar, Berovicˇ, & Pohleven, 2000;Chairul & Hayashi, 1994;Chairul et al, 1991;Dilip de Silva et al, 2006;Gan, Kuo, & Lin, 1998;Lee, Shim, Kim, & Kang, 2006;Ming, Chilton, Fogarty, & Towers, 2002;Nishitoba, Goto, Sato, & Sakamura, 1989; Ro 00 secke & Ko 00 nig, 2000; Shim et al, 2004;Wang & Liu, 2008;Yoshikawa et al, 2002), ergostane-type sterols (Chiang & Ho, 1990;Gan et al, 1998;Kac, Barbieri, Falco, Seldes, & Gros, 1984;Lee et al, 2006;Pettit & Knight, 1962;Provita, Skorkovska´, Urban, & Vystrcˇil, 1980;Ripperger & Budzikiewicz, 1975; Ro 00 secke & Ko 00 nig, 2000; A. Smaˆnia Jr, Delle Monache, E. Smaˆnia, & Cuneo, 1999;Strigina, Elkin, & Elyakov, 1971) and polysaccharides (Di, Chan, Leung, & Huie, 2003;Lee, Y. Park, Ahn, Ka, & S. Park, 2007;Nakashima, Umeda, & Kanada, 1979;Sasaki, Arai, Ikekawa, Chihara, & Fukuoka, 1971;Usui, Iwasaki, & Mizuno, 1981 Usui et al, 1983;Yang, Sun, Yu, Cui, & Tian, 2005) from the fruiting bodies of G. applanatum.…”

Section: Introductionmentioning

confidence: 99%

Polyoxygenated ergostane-type sterols from the liquid culture ofGanoderma applanatum

Lee

Kim

Lee

et al. 2011

Natural Product Research

View full text Add to dashboard Cite

A new polyoxygenated ergostane-type sterol, 3β,5α,6β,8β,14α-pentahydroxy-(22E,24R)-ergost-22-en-7-one (1), has been isolated from the liquid culture of the basidiomycete Ganoderma applanatum together with four known sterols, 3β,5α,9α-trihydroxy-(22E,24R)-ergosta-7,22-dien-6-one (2), ergosterol peroxide (3), 6-dehydrocerevisterol (4) and cerevisterol (5). Two of these sterols (2, 4) are reported to have been isolated from this species for the first time. The structures of these compounds were determined by chemical and spectroscopic analyses, including 1D- and 2D-NMR, as well as by comparison of their spectroscopic data with those reported in the literature.

show abstract

The major sterols from three species of polyporaceae

Cited by 17 publications

References 10 publications

Ganoderma – A therapeutic fungal biofactory

Ganoderma – A therapeutic fungal biofactory

Ganoderma — A Therapeutic Fungal Biofactory

Polyoxygenated ergostane-type sterols from the liquid culture ofGanoderma applanatum

Contact Info

Product

Resources

About